Clinical Trial Update: Magnetic Resonance Imaging (MRI) Follow-up of Macrophagic Infiltration in MS Patients Treated With Tysabri [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on MRI follow-up of macrophagic infiltration in multiple sclerosis patients treated with natalizumab (Tysabri); the study conducte…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Tysabri (Natalizumab)

Snippet

Sponsor: University Hospital, Strasbourg, France | Conditions: Multiple Sclerosis | Phase 4 | Status: TERMINATED